» Articles » PMID: 29205315

Repository Corticotrophin Injection Exerts Direct Acute Effects on Human B Cell Gene Expression Distinct from the Actions of Glucocorticoids

Overview
Date 2017 Dec 6
PMID 29205315
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Repository corticotrophin injection (RCI, H.P Acthar gel) has been approved for use in the management of multiple autoimmune and inflammatory diseases for more than a half-century, but its mechanism of action is not well understood. We used RNA-Seq methods to define RCI-regulated mRNAs in cultured human B cells under conditions of activation by interleukin (IL)-4 and CD40 ligand. Following IL-4/CD40L activation and RCI treatment we found up-regulation of 115 unique mRNA transcripts and down-regulation of 80 unique mRNAs. The effect on these RNA levels was dose-dependent for RCI and was distinct from changes in mRNA expression induced by treatment with a potent synthetic glucocorticoid. RCI down-regulated mRNAs were observed to include a significant over-representation of genes critical for B cell proliferation under activating conditions. These data confirm that RCI exerts direct effects on human B cells to modulate mRNA expression in specific pathways of importance to B cell function and that, at the molecular level, the effects of RCI are distinct from those exerted by glucocorticoids.

Citing Articles

Acthar Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence.

Kaplan J, Askanase A, Chu D, Abdellatif A, Basu D, Mirsaeidi M Clin Drug Investig. 2023; 43(10):739-761.

PMID: 37792273 PMC: 10575998. DOI: 10.1007/s40261-023-01303-5.


Role of topical and systemic immunosuppression in aqueous-deficient dry eye disease.

Kate A, Shanbhag S, Donthineni P, Amescua G, Perez Quinones V, Basu S Indian J Ophthalmol. 2023; 71(4):1176-1189.

PMID: 37026249 PMC: 10276741. DOI: 10.4103/IJO.IJO_2818_22.


A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus.

Askanase A, Furie R Adv Ther. 2022; 39(7):3088-3103.

PMID: 35641860 PMC: 9239929. DOI: 10.1007/s12325-022-02160-y.


Results from a Prospective, Open-Label, Phase 4 Pilot Study of Repository Corticotropin Injection for Moderate and Severe Dry Eye Disease.

Toyos M, Toyos R, Jodoin B, Bunch R Ophthalmol Ther. 2022; 11(3):1231-1240.

PMID: 35460497 PMC: 9114278. DOI: 10.1007/s40123-022-00501-2.


Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review.

Mirsaeidi M, Baughman R Pulm Ther. 2022; 8(1):43-55.

PMID: 35113366 PMC: 8861221. DOI: 10.1007/s41030-022-00181-0.


References
1.
Sekiya T, Kashiwagi I, Yoshida R, Fukaya T, Morita R, Kimura A . Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. Nat Immunol. 2013; 14(3):230-7. DOI: 10.1038/ni.2520. View

2.
Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

3.
Andersen G, Hagglund M, Nagaeva O, Frangsmyr L, Petrovska R, Mincheva-Nilsson L . Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3 and 5 and pro-opio-melanocortin peptide gene expression in subsets of human peripheral blood leucocytes. Scand J Immunol. 2005; 61(3):279-84. DOI: 10.1111/j.1365-3083.2005.01565.x. View

4.
Keshava Prasad T, Kandasamy K, Pandey A . Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. Methods Mol Biol. 2009; 577:67-79. DOI: 10.1007/978-1-60761-232-2_6. View

5.
Schaefer C, Anthony K, Krupa S, Buchoff J, Day M, Hannay T . PID: the Pathway Interaction Database. Nucleic Acids Res. 2008; 37(Database issue):D674-9. PMC: 2686461. DOI: 10.1093/nar/gkn653. View